Ryan's District Boards

AbbVie, one of the two U.S. companies trying to stop Europe's drugs regulator from releasing previously secret clinical trials data, said on Thursday it had withdrawn lawsuits against the watchdog. The decision follows a move by the London-based European Medicines Agency (EMA) to accept a new set of redacted documents submitted by AbbVie, along with the company's rationale for removing certain commercially confidential information. "As a result, AbbVie has withdrawn its lawsuits." The EMA said the "very limited redactions" would have no significant impact on the readability of the clinical study reports that were at the center of the litigation. The legal row between the EMA, AbbVie and a second drugmaker, InterMune, has thrown a spotlight on attempts by parts of the pharmaceutical industry keep its data secret, even as many doctors and campaigners demand greater transparency.